These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2201581)

  • 21. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R; Black V; Hines GA; Fox LM; Boots LR
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Physiopathology and diagnostic criteria of polycystic ovary].
    Kurachi K; Miyazaki M
    Horumon To Rinsho; 1974 Jul; 22(7):791-5. PubMed ID: 4473085
    [No Abstract]   [Full Text] [Related]  

  • 23. Polycystic ovarian disease as a neuroendocrine disorder of the female reproductive axis.
    Hall JE
    Endocrinol Metab Clin North Am; 1993 Mar; 22(1):75-92. PubMed ID: 8095452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathophysiology of the polycystic ovary syndrome].
    Alieva EA; Pshenichnikova TIa; Gasparov AS
    Akush Ginekol (Mosk); 1989 Apr; (4):3-6. PubMed ID: 2665539
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.
    Rochira V; Zirilli L; Genazzani AD; Balestrieri A; Aranda C; Fabre B; Antunez P; Diazzi C; Carani C; Maffei L
    Eur J Endocrinol; 2006 Oct; 155(4):513-22. PubMed ID: 16990650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of the endogenous opioid system in the pathogenesis of polycystic ovary syndrome: the altered neuroendocrine regulation of GnRH-LH is corrected after clomiphene therapy].
    Barletta C; Vagiri D; Scavo D
    Minerva Endocrinol; 1992; 17(3):107-19. PubMed ID: 1298870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.
    Hall JE; Taylor AE; Hayes FJ; Crowley WF
    J Endocrinol Invest; 1998 Oct; 21(9):602-11. PubMed ID: 9856414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.
    Hayes FJ; Taylor AE; Martin KA; Hall JE
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2343-9. PubMed ID: 9661606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.
    Pagán YL; Srouji SS; Jimenez Y; Emerson A; Gill S; Hall JE
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1309-16. PubMed ID: 16434454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea.
    Carmina E; Fruzzetti F; Lobo RA
    Am J Obstet Gynecol; 2016 Jun; 214(6):714.e1-6. PubMed ID: 26767792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothalamic-pituitary-ovarian function in menstruating women with Turner syndrome (45,X).
    Page LA; Beauregard LJ; Bode HH; Beitins IZ
    Pediatr Res; 1990 Nov; 28(5):514-7. PubMed ID: 2255575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial polycystic ovarian disease.
    Givens JR
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):771-83. PubMed ID: 3058473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease.
    Paradisi R; Venturoli S; Pasquali R; Capelli M; Porcu E; Fabbri R; Flamigni C
    J Endocrinol Invest; 1986 Apr; 9(2):139-44. PubMed ID: 3086422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene.
    Belgorosky A; Pepe C; Marino R; Guercio G; Saraco N; Vaiani E; Rivarola MA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5127-31. PubMed ID: 14602738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Regulating effect on the hypothalamo-hypophyseo-ovarian axis observed during the process of treating polycystic ovarian disease by tonifying the kidney and resolving phlegm].
    Yu J
    Zhong Xi Yi Jie He Za Zhi; 1986 Apr; 6(4):218-21, 195-6. PubMed ID: 2945659
    [No Abstract]   [Full Text] [Related]  

  • 38. Interrelationship between excessive levels of circulating androgens in blood and ovulatory failure.
    Parker CR; Mahesh VB
    J Reprod Med; 1976 Aug; 17(2):75-90. PubMed ID: 134158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
    Blank SK; McCartney CR; Marshall JC
    Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.